Psychometric evaluation of the pediatric applied cognition scale in pediatric hematology/oncology

ABSTRACT

Pediatric patients with hematology and oncology conditions often experience disease- and treatment-related neurocognitive deficits. Well-validated screening tools are critical for identifying patients experiencing cognitive impairments. The Pediatric Applied Cognition scale (PAC) Short Form, developed by the National Institutes of Health, assesses attention and memory concerns. The current study is the first to examine the psychometrics of the PAC in pediatric patients with hematology/oncology conditions. Pediatric patients (n = 222) and caregivers completed the PAC and self-report measures of psychosocial and academic functioning. Results revealed strong internal consistency for the Child (α = 0.81–0.89) and Parent (α = 0.92–0.95) PAC. More cognitive concerns on the Child/Parent PAC were associated with greater psychosocial concerns (e.g. anxiety, depression, and fatigue) and lower reported school grades. The Parent PAC incrementally predicted child reported symptoms of depression, mobility concerns, and school grades beyond the Child PAC. Overall, the PAC Short Form may be useful as an indicator of general academic and psychosocial concerns. Further research validating the PAC in relation to performance-based neurocognitive outcomes and academic achievement is needed in children treated for hematology/oncology conditions.

KEYWORDS:

• Attention
• screening
• pediatrics
• hematology
• oncology
• PROMIS

Acknowledgments

The authors would like to acknowledge and thank the families that participated to complete study questionnaires.

Disclosure statement

The authors have no conflicting interests.

Supplementary material

Supplemental data for this article can be accessed here.